Friday, September 30, 2005

Update: DC Office up and Running!

Our network continues to grow. With offices already in Prague, Dubai, and New York, we are currently expanding our neoconsulting network to Washington, DC. Our top priorities for the region are grassroots mobilization, aggressive lobbying, and comprehensive litigation. For maps and satellite images of the new office, see:,+Washington,+DC.

Wednesday, September 28, 2005

Looking for Immigration and Employment Neoconsulting

An overseas colleague from our Karachi office, Amer Ahmed, has encountered a snag at the Bureau of Citizenship and Immigration Services. We are currently searching for a dynamic solution to this static situation. Legal remedies are all but exhausted; forgeries and sneakery may be ill-advised at this juncture. One of our subsidiaries has invested massive capital in an italian import-export business, as well as in some smaller electronics side-projects, most notably involving an emerging Thai producer, known as Insignia. Unfortunately, this latest snag has put our credit line in jeopardy. We welcome all bids, on a non-binding, interest-free, contingency basis.

Wednesday, May 04, 2005

Research Offers New Opportunities in Bio-neoconsulting

Constantly pushing the boundaries -- this is what neoconsulting is all about. Simply put, Sarah E. Umetsu has discovered the next frontier; the abstract speaks for itself:

We have examined the function of TIM-1, encoded by a gene identified as an 'atopy susceptibility gene' (Havcr1 *), and demonstrate here that TIM-1 is a molecule that costimulates T cell activation. TIM-1 was expressed on CD4+ T cells after activation and its expression was sustained preferentially in T helper type 2 (TH2) but not TH1 cells. In vitro stimulation of CD4+ T cells with a TIM-1-specific monoclonal antibody and T cell receptor ligation enhanced T cell proliferation; in TH2 cells, such costimulation greatly enhanced synthesis of interleukin 4 but not interferon-. In vivo, the use of antibody to TIM-1 plus antigen substantially increased production of both interleukin 4 and interferon- in unpolarized T cells, prevented the development of respiratory tolerance, and increased pulmonary inflammation. Our studies suggest that immunotherapies that regulate TIM-1 function may downmodulate allergic inflammatory diseases.

Sunday, May 01, 2005

Neoconsulting Extraordinaire

Greg Page has been in the business for years. His talent is available to VIPs only. After building one of the most elite and powerful client lists in the industry, he is now on sabbatical, providing his services to another VIP: The United States of America. While we are honored to provide his clients with our services in his absence, we hope that he returns (perhaps bringing a new perspective with his advanced intelligence training).

Saturday, April 16, 2005

Neoconsulting Employment in Brazil

The neoconsulting employment industry is booming. Latin America alone has experienced a 74% jump in market share and a 14% salary increase for top executives over the last 3 fiscal quarters. Our associate Rubens Gimael forecasts continued growth for the next 5-7 years. If training can keep pace with demand, a weak US dollar may be the limiting factor.

Friday, April 15, 2005

What Is Neoconsulting?

Neoconsulting is often confused, especially in European circles, with Le Consult Nouveau, a French offshoot composed primarily of international development consultants focused on the once emerging third-world market in military textiles. Although short-lived for obvious reasons, Le Consult Nouveau had a lasting impact on analytical methodology. The push toward a proprietary system, as exemplified by the current neoconsulting framework, was essentially a response to. . . (more)

Legal Notice

Publication of forthcoming materials subject to AGP Terms and Conditions. (more)